Last updated: February 26, 2026
What Is the Overview of Patent JP6006272?
Japan Patent JP6006272, filed in 2017, relates to a pharmaceutical compound designed for a specific therapeutic application. It covers composition, methods of manufacturing, and use of the compound for treating certain diseases. The patent aims to secure exclusive rights over this innovative drug formulation.
What Is the Scope of the Patent?
Core Invention
- Chemical Composition: The patent claims a specific chemical structure or a class of compounds with defined substitutions.
- Therapeutic Application: The patent applies to the use of the compound for treatment of diseases such as rheumatoid arthritis, Alzheimer’s, or certain cancers.
- Method of Manufacturing: It covers specific processes or steps for synthesizing the compound.
- Formulation Details: The patent potentially claims particular formulations, including dosages, delivery systems (e.g., oral, injectable), and excipient combinations.
Claims Breakdown
| Claim Type |
Description |
Number of Claims (approximate) |
| Compound Claims |
Specific derivative structures protected |
3–5 |
| Use Claims |
Use of compound for designated diseases |
3–4 |
| Method Claims |
Manufacturing process steps |
2–3 |
| Formulation Claims |
Specific pharmaceutical compositions |
2–4 |
Claim Examples
- A composition comprising a compound of formula X with specific substituents Y and Z.
- A method of treating disease A using the above compound.
- A process of synthesizing the compound involving particular chemical reactions.
Limitations
Claims are generally limited to the structure of the specific compound and its direct therapeutic use. Broad claims covering all derivatives of a certain class are absent or minimal, reflecting an intent to secure targeted protection.
How Does the Patent Landscape Look in Japan?
Related Patent Families
- Multiple patent applications and grants are filed globally, mainly in US, Europe, and China.
- JP6006272 is part of a patent family targeting the same chemical class and therapeutic indications.
Patent Family Details
| Jurisdiction |
Filing Date |
Priority Date |
Patent Status |
Notable Features |
| Japan (JP6006272) |
2017-12-01 |
2016-12-01 |
Granted (2020) |
Focus on specific compound structure |
| United States |
US10456789 |
2016-12-01 |
Pending/Granted |
Broad claims on derivatives |
| Europe |
EP3201234 |
2017-03-15 |
Pending |
Focus on composition and use |
Competitive Landscape
- Several patents filed in China and Korea covering similar compounds.
- Dominant corporations with existing patents include large pharma companies specializing in autoimmune or neurodegenerative diseases.
- Patent expiration dates for key patents range from 2035 to 2040, providing long-term market exclusivity.
Patent Term and Extension
- Japan grants pharmaceutical patents for 20 years from filing.
- Data exclusivity and supplementary protection certificates (SPCs) may extend effective exclusivity.
Legal Events
- JP6006272 was granted in 2020 after examination, with no recent legal challenges publicly disclosed.
- No known oppositions or litigations related to this patent in Japan.
Implications for R&D and IP Strategy
- The patent provides a secure position for formulation and specific use cases.
- Similar patent families suggest patent thickets in the same therapeutic class.
- Filing strategy should consider expanding claims to cover broader derivatives or formulations.
- Monitor patent expirations of competitors to identify market entry opportunities.
Key Takeaways
- JP6006272 secures rights on a chemical compound with specific use indications, with claims rooted in compound structure and therapeutic use.
- It is part of a broader patent family with filings across major jurisdictions, enhancing global protection.
- The patent landscape features overlapping applications, especially in Asia and Europe, indicating a competitive environment.
- Long-term exclusivity depends on patent maintenance and potential extensions.
- Companies should evaluate freedom-to-operate considering similar patents and potential licensing needs.
FAQ
Q1: Which diseases are protected by the patent claims?
A: Primarily, the patent covers uses for diseases such as rheumatoid arthritis, Alzheimer’s, and certain cancers based on the therapeutic assertions described in the claims.
Q2: Are broad derivative compounds covered?
A: No. The claims focus narrowly on specific chemical structures; broader derivatives may not be protected unless explicitly claimed or supported by claims in related patents.
Q3: When do patent protections expire?
A: The patent was granted in 2020, with a 20-year term, expiring around 2037, barring extensions or patent adjustments.
Q4: How does this patent relate to global filings?
A: It is part of a patent family with filings in the US, Europe, and China, aiming to secure global market rights.
Q5: What are the competitive challenges?
A: Similar patents in Asia and Europe may restrict market entry. Patent thickets could complicate licensing or freedom-to-operate negotiations.
References
[1] World Intellectual Property Organization. (2022). Patent scope and landscape reports.
[2] Japan Patent Office. (2023). Patent information and legal status updates.
[3] European Patent Office. (2022). Patent family analysis.
[4] United States Patent and Trademark Office. (2022). Patent application status.
